| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 10/18/2007 | WO2007116687A1 Heterocyclic compound and luminescence method |
| 10/18/2007 | WO2007116417A1 Novel dna methylation markers useful for the diagnosis of neoplastic diseases |
| 10/18/2007 | WO2007116414A1 Single tube multiplex assay for detection of adulterants in basmati rice samples |
| 10/18/2007 | WO2007116298A2 Nucleic acid detection using lateral flow methods |
| 10/18/2007 | WO2007116129A1 A universal labeling system |
| 10/18/2007 | WO2007116096A1 Brassica oleracea plants with a resistance to mycosphaerella brassicicola |
| 10/18/2007 | WO2007116069A1 Method for suppressing a fret signal, fret signal suppressor agents and use in a method for multiplexing biological events |
| 10/18/2007 | WO2007115702A2 Mixture of reversibly inhibited enzymes |
| 10/18/2007 | WO2007115590A1 Detection and quantification of faecal pollution in an environmental sample |
| 10/18/2007 | WO2007115582A1 Hpv detection and quantification by real-time multiplex amplification |
| 10/18/2007 | WO2007115491A1 Rapid genotyping analysis and the device thereof |
| 10/18/2007 | WO2007115467A1 Method of predicting administrating safety of oseltamivir phosphate medicine |
| 10/18/2007 | WO2007115444A1 Seperation or analysis composition comprising active nanostructure and seperation or analysis method |
| 10/18/2007 | WO2007115407A1 Modification of xylanases to increase thermophilicity, thermostability and alkalophilicity |
| 10/18/2007 | WO2007115344A1 Set of oligonucleotides |
| 10/18/2007 | WO2007096197A3 Methods for predicting the response of multiple sclerosis patients to interferon therapy and diagnosing multiple sclerosis |
| 10/18/2007 | WO2007094818A3 Novel hiv targets |
| 10/18/2007 | WO2007093049A9 Kinase and phosphatase assays conducted by elemental analysis |
| 10/18/2007 | WO2007088506A3 Kit for the amplification of nucleic acids |
| 10/18/2007 | WO2007083246A3 Vegf variants |
| 10/18/2007 | WO2007060707A3 Reagents and method for simultaneous nucleic acid amplification and detection |
| 10/18/2007 | WO2007059514A3 Sers-based methods for detection of bioagents |
| 10/18/2007 | WO2007059430A3 Moesin, caveolin 1 and yes associated protein 1 as predictive markers of response to dasatinib in breast cancers |
| 10/18/2007 | WO2007053785A3 Method for early detection of various cancers and gastrointestinal disease and monitoring of transplanted organs. |
| 10/18/2007 | WO2007014132A3 Hmgcr isoforms in prediction of efficacy and identification of cholesterol-modulating compounds |
| 10/18/2007 | WO2006127956A3 Rapid production of adenovirus-free recombinant adenovirus vectors |
| 10/18/2007 | WO2006102401A3 Normalization of gene expression data |
| 10/18/2007 | WO2006083721A3 Purification process for piasmid dna |
| 10/18/2007 | WO2006082496A8 Method for determining hiv-1 viral load |
| 10/18/2007 | WO2005103303A3 Apparatus and method for transdermal delivery of multiple vaccines |
| 10/18/2007 | WO2005067391A3 Diagnostic test for parkinson's disease |
| 10/18/2007 | WO2004058989A3 Target-dependent transcription |
| 10/18/2007 | WO2003074728A3 Screening for modulators of pkng activity |
| 10/18/2007 | WO2002061054A3 Method for increasing the virus propagation and the virus yield in cell cultures by blocking the activation of rnasel |
| 10/18/2007 | WO2002010354A3 Secretase/sheddase with asp-ase activity on the beta-site app-cleaving enzyme (bace, asp2, memepsin 2) |
| 10/18/2007 | WO2002010198A3 Polynucleotides and polypeptides |
| 10/18/2007 | US20070244313 Method for detecting base mutation |
| 10/18/2007 | US20070244310 Minimally cross-hybridizing nucleotide sequences; provides of a family of molecules which is sufficiently large and where each individual member is sufficiently selective for its complement over all the other zipcode molecules |
| 10/18/2007 | US20070244309 Organic conductor |
| 10/18/2007 | US20070244298 Polynucleotide encoding a variant polypeptide of wild-type DsRed or DsRed.T4, a tetrameric variant that has reduced oligomerization relative wild-type DsRed and a fluorescence spectra similar to the fluorescence spectra of the wild-type DsRed |
| 10/18/2007 | US20070244297 Human calcium channel compositions and methods |
| 10/18/2007 | US20070244165 Method for Identifying and Producing Effectors of Calmodulin-Dependent Peptidyl-Prolyl Cis/Trans Isomers |
| 10/18/2007 | US20070244098 Dual Small Molecule Inhibitors of Cancer and Angiogenesis |
| 10/18/2007 | US20070244083 Using fluorouracil and/or oxaliplatin as diagnostic tools in detection of SCN1A-T1067A-SNP genetic polymorphism in the preferential and diagnosis of colorectal cancer |
| 10/18/2007 | US20070244063 Inducing angiogenesis comprising contacting endothelial cells expressing Bv8 receptor with a polypeptide comprising the amino acid sequence of SEQ ID NO:2; using Bv8 polypeptides to induce endothelial cell proliferation and to enhance endothelial cell survival; screening for Bv8 modulators |
| 10/18/2007 | US20070244061 Compositions for Diagnosis and Therapy of Diseases Associated with Aberrant Expression of Futrins (R-Spondisn) and/or Wnt |
| 10/18/2007 | US20070244035 Novel co-modulators of nuclear receptors and methods of detecting and treating steroid hormone-dependent diseases using same |
| 10/18/2007 | US20070244031 Methods and Compositions for Homozygous Gene Inactivation Using Collections of Pre-Defined Nucleotide Sequences Complementary Chromosomal Transcripts |
| 10/18/2007 | US20070244030 Method for Assessing Cancerous State |
| 10/18/2007 | US20070243601 Method for Stabilizing Assay Reagents, Reagent Container with Stabilized Assay Reagents and Use Thereof |
| 10/18/2007 | US20070243600 System for performing multi-formatted assays |
| 10/18/2007 | US20070243577 Method for the detection of apoptosis by determining apoptosis-specific markers released into an extracellular medium through cellular release mechanisms |
| 10/18/2007 | US20070243576 Method to confirm immunosuppression in human patients by measuring lymphocyte activation |
| 10/18/2007 | US20070243575 Compositions and methods for treatment of immune-related disease |
| 10/18/2007 | US20070243574 Vascular mimic for drug and device evaluation |
| 10/18/2007 | US20070243573 Method and apparatus for immobilizing cells, and cell-immobilized substrate |
| 10/18/2007 | US20070243572 Interacting Microhabitat Array and Uses Thereof |
| 10/18/2007 | US20070243571 Method for Measurement of Activity of Homocysteinethiolactone Hydrolyzing Enzyme |
| 10/18/2007 | US20070243570 Apoptosis Inducer for Cancer Cell |
| 10/18/2007 | US20070243569 producing a kinase/phosphatase inducible domain by replacing a structurally significant glutamic acid or aspartic acid residue in an EF hand domain with a replacement serine or threonine residue; producing a phosphorylation-dependent protein domain; Alzheimer's and heart disease |
| 10/18/2007 | US20070243568 Specific Substrates for O6-Alkylguanine-Dna Alkyltransferase |
| 10/18/2007 | US20070243567 Beta cell mimicking control algorithm for artificial pancreas |
| 10/18/2007 | US20070243566 Amino acid residue insertion between an amino acid positions corresponding to positions 428 and 429 of the s-GDH wild-type sequence known from Acinetobacter calcoaceticus; method for measurement of glucose, especially by a tests strip device or with a biosensor |
| 10/18/2007 | US20070243564 Identification of Antibody-Producing Cells |
| 10/18/2007 | US20070243553 Analytical Method and Kit |
| 10/18/2007 | US20070243552 Novel approach to molecular diagnosis of human papillomavirus-related diseases |
| 10/18/2007 | US20070243551 Assay System Using Labeled Oligonucleotides |
| 10/18/2007 | US20070243550 Molecular Detection and Quantification of Enterococci |
| 10/18/2007 | US20070243549 Enrichment of circulating fetal dna |
| 10/18/2007 | US20070243548 Calumenin-directed diagnostics and therapeutics for cancer and chemotherapeutic drug resistance |
| 10/18/2007 | US20070243547 Use of tumor susceptibilty gene 101 (TSG 101) as a prognostic and diagnostic marker |
| 10/18/2007 | US20070243546 Analysis of methylation using nucleic acid arrays |
| 10/18/2007 | US20070243545 Method for combining immunostaining and fish using covalently binding fluorophores |
| 10/18/2007 | US20070243544 Compositions for use in identification of bacteria |
| 10/18/2007 | US20070243543 Method for Isolation of Transcription Termination Sequences |
| 10/18/2007 | US20070243542 Use of a weakly basic polymer for the capture and selective release of the captured nucleic acids from the polymer; Upon binding DNA the polymer becomes insoluble |
| 10/18/2007 | US20070243541 Compositions and methods for generating antigen-binding units |
| 10/18/2007 | US20070243540 Kits and Methods for Identification, Assessment, Prevention and Therapy of Breast Cancer |
| 10/18/2007 | US20070243539 Genetic variants of human inositol polyphosphate-4-phosphatase, type i (inpp4a) useful for prediction and therapy of immunological disorder |
| 10/18/2007 | US20070243538 Detecting in a dog a mutation that causes autosomal recessive Alport Syndrome in English Cocker Spaniels by analyzing biological sample for presence of a indicative sequence; identifying ingle nucleotide polymorphisms (SNPs); microsatellite marker t segregates with Alport Syndrome |
| 10/18/2007 | US20070243537 Human sample matching system |
| 10/18/2007 | US20070243536 designing oligonucleotide primers specific for gene of interest and performing successive rounds of PCR amplification of nucleic acid material from a microorganism, particularly Bacillus thuringiensis, to identify novel homologues of known pesticidal genes; permits rapid and efficient screening |
| 10/18/2007 | US20070243535 Methods for increasing accuracy of nucleic acid sequencing |
| 10/18/2007 | US20070243534 Probe density considerations and elongation of self-complementary looped probes where probes are attached to a solid phase |
| 10/18/2007 | US20070243533 Products and methods of organism identification in nutritional supplements |
| 10/18/2007 | US20070243532 System and Method of Detecting a Microorganism |
| 10/18/2007 | US20070243531 Methods of Diagnosing Colorectal Cancer and Reagents Therefor |
| 10/18/2007 | US20070243530 Nucleic Acid Probes and Broad-Range Primers from Regions in Dna Directed Rna Polymerase Subunit B Genes, and Methods in Which They are Used |
| 10/18/2007 | US20070243529 Aptamer Selection Method |
| 10/18/2007 | US20070243528 Methods for detecting polymorphisms using arms or rflp |
| 10/18/2007 | US20070243527 Useful for imparting fluorescent properties to target materials by covalent and non-covalent association; fluorescent markers |
| 10/18/2007 | US20070243525 Method and a device for the evaluation of biopolymer fitness |
| 10/18/2007 | US20070243524 sequences from the Core/E1 region of HCV type 3; detection of HCV infection |
| 10/18/2007 | US20070243523 Methods and Apparatus for the Manipulation of Particle Suspensions and Testing Thereof |
| 10/18/2007 | US20070243521 Method and apparatus for the non-invasive measurement of tissue function and metabolism by determination of steady-state fluorescence anisotropy |
| 10/18/2007 | US20070243520 Method for screening an agent for preventing or ameliorating wrinkles |
| 10/18/2007 | US20070243519 Protecting group for carboxylic acids that can be photolyzed by visible light |
| 10/18/2007 | US20070243214 Genes and proteins associated with angiogenesis and uses thereof |
| 10/18/2007 | US20070243213 Hbv Variants Detection and Application |
| 10/18/2007 | US20070243202 Tumor necrosis factor receptor-associated factors |